The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.
From Sarah Boseley's Global Health Blog: Multi-drug resistant tuberculosis is on on the rise and hard to cure. Médecins Sans Frontières wants people with the disease to blog about it, to find out what they really need.
No doubt strides have been made in giving more people access to anti-retroviral drugs. But will the progress continue? Jim Clancy put that question to Emi Maclean, Director of the Doctors Without Borders Access Campaign.